AIDS oncology

Infectious Disease Clinics of North America

Volumn 14, Issue 4, 2000, Pages 945-965

  O'Connor, Paula G ^b   Scadden, David T ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER STAGING; CLINICAL FEATURE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; NONHODGKIN LYMPHOMA;

EID: 0034494013     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70141-0     Document Type: Article

References (109)

1. Hodgkin's disease during HIV-1 infection: The French Registry experience. French Registry of HIV Associated Tumors
2. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma
3. An epidemiologic study of cervical neoplastic disease: Based on a self-selected sample of 7000 women in Barbados, West Indies
4. Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome
5. AIDS-related malignancies
6. AIDS-associated non-Hodgkin's lymphoma
7. The epidemiology of AIDS-related neoplasms
8. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with injection
9. AIDS associated mucocutaneous Kaposi's sarcoma treated with bleomycin
10. Revised classification system for HIV infection and cervical neoplasia: Implications for clinical care of women at risk for both conditions
11. Kaposi's sarcoma-associated herpesvirus: A lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease
12. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus
13. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system
14. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin gel. Panretin Gel North American Study Group
15. Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma
16. Reed-Sternberg cell: Survival in a hostile sea
17. AIDS and cancer registry linkage: Measurement and enhancement of registry completeness: The National AIDS/Cancer Match Study Group
18. Prospective study of high grade anal squamous cell intra-epithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection
19. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection
20. Burkitt-like lymphomas in AIDS patients: Characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group
21. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy
22. Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma
23. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma
24. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel
25. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
26. Combined modality therapy in the treatment of primary central nervous system lymphoma in AIDS
27. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma
28. Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial
29. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
30. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin and vincristine in AIDS-related Kaposi's sarcoma
31. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy
32. Use of antiherpes drugs and the risk of Kaposi's sarcoma: Data from the multicenter AIDS Cohort Study
33. Spectrum of AIDS-associated malignant disorders
34. HIV-associated Hodgkin's disease: A clinical study of 18 cases and review of the literature
35. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin
36. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site
37. Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma
38. Clinical simulators of the lesions of Kaposi's sarcoma
39. Pathogenesis of AIDS lymphoma
40. Acquired immunodeficiency-associated T-cell lymphoma: Evidence for human immunodeficiency virus type 1-associated T-cell transformation
41. Increased incidence of Hodgkin's disease in homosexual men with HIV infection
42. Abdominal imaging in AIDS: Abdominal CT and ultrasound
43. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons
44. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
45. AIDS-associated non-Hodgkins's lymphoma in San Francisco
46. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus associated non-Hodgkin's lymphoma: Results of a randomized trial
47. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection
48. Human herpesvirus 8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: A unique B-cell neoplasm
49. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
50. Etiology and pathogenesis of AIDS-related-non-Hodgkin's lymphoma
51. Long-term follow-up of 1121 cases of carcinoma in situ
52. Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: A prospective pilot study
53. Kaposi's sarcoma in the acquired immunodeficiency syndrome: A proposal for uniform evaluation
54. The biology of human papillomaviruses: From warts to cancer
55. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine
56. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma
57. Low-dose chemotherapy with central nervous system prophylaxis zidovudine maintenance in AIDS-related lymphoma
58. Hodgkin's disease in the setting of human immunodeficiency virus infection
59. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
60. Dose adjusted EPOCH chemotherapy (CT) in previously untreated HIV-associated non-Hodgkin's lymphoma (HIV-NHL): Preliminary report of efficacy, immune reconstitution, and HIV control following therapy
61. Autopsy findings in AIDS-related lymphoma
62. AIDS-related lymphoid neoplasia: The Memorial Hospital experience
63. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome
64. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease
65. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men
66. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group
67. The invasive potential of carcinoma in situ of the cervix
68. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
69. Anti-tumor activity of oral 9-cis-retinoic acid in AIDS related Kaposi's sarcoma: AIDS malignancy consortium study 002
70. Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with acquired immunodeficiency syndrome
71. + cells in advanced HIV-1 disease
72. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection
73. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus
74. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection
75. The Epstein-Barr virus transforming protein LMP-1 engages signaling proteins for the tumor necrosis factor receptor family
76. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
77. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus
78. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients
79. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease
80. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
81. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men
82. Anal squamous intraepithelial lesions: Relation to HIV and human papillomavirus infection
83. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in alternating regimen with azidothymidine in leukopenia patients with severe human immunodeficiency virus infection
84. Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous KS
85. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2
86. Chemotherapy for HIV-associated non-Hodgkin's lymphoma (NHL) in combination with highly active antiretroviral therapy (HAART) is not associated with excessive toxicity
87. Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS
88. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma
89. Hodgkin's disease in patients with antibodies to human immunodeficiency virus. A study of 22 patients
90. Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency-associated lymphomas
91. Molecular and immunophenotypic characterization of AIDS-associated, Epstein Barr virus-negative, polyclonal lymphoma
92. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide (CDE) in HIV-associated non-Hodgkin's lymphoma (NHL): An Eastern Cooperative Oncology Group (ECOG) trial (E1494)
93. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group
94. Prognostic factors in the treatment of HIV-associated non-Hodgkin's lymphoma. Analysis of AIDS Malignancy Clinical Group (ACTG) Protocol 142: Low-dose vs. standard-dose m-BACOD + GM-CSF
95. Highly active anti-retroviral therapy in HIV-related Kaposi's sarcoma
96. Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors
97. Prospective study with combined lowdose chemotherapy and zidovudine in 37 patients with poor prognosis AIDS-related non-Hodgkin's lymphoma
98. Treatment of HIV-related non-Hodgkin's lymphoma adapted to prognostic factors
99. Acquired immunodeficiency syndrome (AIDS) - United States
100. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients
101. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription
102. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice
103. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome
104. Patients with advanced AIDS-related Kaposi's sarcoma no longer require systemic therapy after introduction of effective anti-retroviral therapy
105. GI imaging in AID - Luminal gastrointestinal tract
106. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
107. Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages